ID   ChMC
AC   CVCL_WH49
DR   Wikidata; Q93450979
RX   PubMed=24035468;
RX   PubMed=27292541;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
RX   PubMed=24035468; DOI=10.1016/j.tvjl.2013.08.003;
RA   Ito, Keita
RA   Kobayashi, Masato
RA   Kuroki, Shiori
RA   Sasaki, Yu
RA   Iwata, Taisuke
RA   Mori, Kohei
RA   Kuroki, Tetsuya
RA   Ozawa, Yuta
RA   Tetsuka, Masanori
RA   Nakagawa, Tomoko
RA   Hiroi, Teruyo
RA   Yamamoto, Hitomi
RA   Ono, Kenichiro
RA   Washizu, Tsukimi
RA   Bonkobara, Makoto
RT   "The proteasome inhibitor bortezomib inhibits the growth of canine
RT   malignant melanoma cells in vitro and in vivo.";
RL   Vet. J. 198:577-582(2013).
//
RX   PubMed=27292541; DOI=10.1111/jvp.12336;
RA   Kuroki, Shiori
RA   Kobayashi, Masato
RA   Tani, Hiroyuki
RA   Miyamoto, Ryo
RA   Kurita, Sena
RA   Tamura, Kyoichi
RA   Ono, Kenichiro
RA   Washizu, Tsukimi
RA   Bonkobara, Makoto
RT   "Selective growth inhibition by suppression of F1Fo ATPase in canine
RT   malignant melanoma cell lines.";
RL   J. Vet. Pharmacol. Ther. 40:101-104(2017).
//